account_num,net_change,tag,tag_depth,cik
645,26430000.0,CashAndCashEquivalentsAtCarryingValue,3,924717_SURMODICS INC
577,26430000.0,CashCashEquivalentsAndShortTermInvestments,4,924717_SURMODICS INC
229,10068000.0,AccountsReceivableNetCurrent,3,924717_SURMODICS INC
722,3000.0,AccretionExpense,1,924717_SURMODICS INC
375,12743000.0,ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost,2,924717_SURMODICS INC
914,1965000.0,AllocatedShareBasedCompensationExpense,2,924717_SURMODICS INC
525,3000.0,AccretionExpenseIncludingAssetRetirementObligations,2,924717_SURMODICS INC
3279,-4115000.0,DeferredRevenueNoncurrent,2,924717_SURMODICS INC
2673,-4410000.0,EmployeeRelatedLiabilitiesCurrent,2,924717_SURMODICS INC
1631,-125000.0,ForeignCurrencyTransactionGainLossBeforeTax,2,924717_SURMODICS INC
2710,-3771000.0,DeferredRevenueCurrent,2,924717_SURMODICS INC
2731,-10000000.0,ShortTermBorrowings,1,924717_SURMODICS INC
2603,-24933000.0,NoninterestIncome,1,924717_SURMODICS INC
110,-24933000.0,RevenueFromContractWithCustomerExcludingAssessedTax,2,924717_SURMODICS INC
581,12746000.0,OperatingCostsAndExpenses,2,924717_SURMODICS INC
491,12743000.0,ResearchAndDevelopmentExpense,2,924717_SURMODICS INC
59,-140000.0,AllowanceForDoubtfulAccountsReceivableCurrent,3,924717_SURMODICS INC
144,5267000.0,CostOfRevenue,1,924717_SURMODICS INC
3809,-4617000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,924717_SURMODICS INC
3750,-30224000.0,AdditionalPaidInCapital,1,924717_SURMODICS INC
3661,-706000.0,CommonStockValue,3,924717_SURMODICS INC
3465,-62494000.0,Liabilities,1,924717_SURMODICS INC
3645,-45230000.0,LiabilitiesNoncurrent,2,924717_SURMODICS INC
3796,-15735000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,924717_SURMODICS INC
3303,-29495000.0,LongTermDebtAndCapitalLeaseObligations,2,924717_SURMODICS INC
3308,-29495000.0,LongTermDebtNoncurrent,2,924717_SURMODICS INC
3154,-17264000.0,LiabilitiesCurrent,2,924717_SURMODICS INC
2638,-10000000.0,DebtCurrent,2,924717_SURMODICS INC
2347,-9083000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,924717_SURMODICS INC
2398,-2035000.0,AccountsPayableCurrent,2,924717_SURMODICS INC
2089,169755000.0,Assets,1,924717_SURMODICS INC
3834,-80948000.0,RetainedEarningsAccumulatedDeficit,1,924717_SURMODICS INC
2091,105293000.0,AssetsNoncurrent,2,924717_SURMODICS INC
1827,72570000.0,IntangibleAssetsNetIncludingGoodwill,2,924717_SURMODICS INC
1732,29262000.0,IntangibleAssetsNetExcludingGoodwill,2,924717_SURMODICS INC
1711,43308000.0,Goodwill,1,924717_SURMODICS INC
1368,27717000.0,PropertyPlantAndEquipmentNet,4,924717_SURMODICS INC
868,64462000.0,AssetsCurrent,2,924717_SURMODICS INC
260,12724000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,924717_SURMODICS INC
455,12724000.0,InventoryNet,2,924717_SURMODICS INC
320,10189000.0,ReceivablesNetCurrent,3,924717_SURMODICS INC
207,10068000.0,AccountsNotesAndLoansReceivableNetCurrent,4,924717_SURMODICS INC
2041,5006000.0,OtherAssetsNoncurrent,2,924717_SURMODICS INC
171,5267000.0,CostOfGoodsAndServicesSold,2,924717_SURMODICS INC
3316,-107261000.0,StockholdersEquity,1,924717_SURMODICS INC
3917,-169755000.0,LiabilitiesAndStockholdersEquity,2,924717_SURMODICS INC
3733,-30224000.0,AdditionalPaidInCapitalCommonStock,2,924717_SURMODICS INC
3494,-9518000.0,OtherLiabilitiesNoncurrent,2,924717_SURMODICS INC
3383,-2102000.0,DeferredIncomeTaxLiabilitiesNet,2,924717_SURMODICS INC
2552,-7048000.0,AccruedLiabilitiesCurrent,2,924717_SURMODICS INC
644,121000.0,NontradeReceivablesCurrent,2,924717_SURMODICS INC
599,121000.0,IncomeTaxesReceivable,2,924717_SURMODICS INC
2903,-7843000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,924717_SURMODICS INC
2590,-7843000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,924717_SURMODICS INC
1912,-7843000.0,NetIncomeLoss,1,924717_SURMODICS INC
1077,-7843000.0,ProfitLoss,2,924717_SURMODICS INC
1820,-8173000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,924717_SURMODICS INC
2399,165000.0,IncomeTaxExpenseBenefit,1,924717_SURMODICS INC
3260,-107261000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,924717_SURMODICS INC
819,107000.0,DeferredIncomeTaxExpenseBenefit,1,924717_SURMODICS INC
2149,-8834000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,924717_SURMODICS INC
1854,826000.0,InterestAndDebtExpense,2,924717_SURMODICS INC
1709,826000.0,InterestExpense,1,924717_SURMODICS INC
2130,-779000.0,NonoperatingIncomeExpense,1,924717_SURMODICS INC
1205,-172000.0,InvestmentIncomeNonoperating,2,924717_SURMODICS INC
1665,-172000.0,InvestmentIncomeNet,2,924717_SURMODICS INC
1264,-7229000.0,OperatingIncomeLoss,1,924717_SURMODICS INC
1112,26041000.0,OperatingExpenses,1,924717_SURMODICS INC
692,59000.0,ProvisionForDoubtfulAccounts,2,924717_SURMODICS INC
601,13236000.0,SellingGeneralAndAdministrativeExpense,3,924717_SURMODICS INC
597,1965000.0,GeneralAndAdministrativeExpense,2,924717_SURMODICS INC
232,-5267000.0,GrossProfit,1,924717_SURMODICS INC
2257,-8008000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,924717_SURMODICS INC
